13F HOLDINGS REPORT
Kinnevik AB (publ)
Quarter ended Q2 2023 · Filed April 14, 2023 · Accession 0001104659-23-045575
Total Value
$74.5M
Positions
2
Other Managers
1
Confidential Omitted
No
Holdings (2)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Recursion Pharmaceuticals, Inc. | RXRX | 7,653,061 | $51.0M | 68.47% |
| 2 | Babylon Holdings Ltd | BABB | 4,617,340 | $23.5M | 31.53% |